IP Library Granted Patent US 9,365,562
Granted Patent B2
US 9,365,562 · App. 14/349,041 · Granted Jun 14, 2016

1,3 substituted azetidine PDE10 inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,365,562
App. No.
14/349,041
Granted
Jun 14, 2016
Kind
B2
Abstract

The present invention is directed to substituted azetidine compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Claims (182)

1. A compound of the formula I:

wherein:

X 1 , X 2 and X 3 independently are CH, or N

R is selected from the group consisting of H, and C 1-6 alkyl;

R 2 is selected from the group consisting of H, O—C 1-6 alkyl, C 1-6 alkyl, C 1-3 haloalkyl, (CH 2 ) n C 3-10 cycloalkyl, CN; (CH 2 ) n C 5-10 heterocycle, said alkyl, cycloalkyl, and heterocycle, optionally substituted with 1 to 3 groups of R a ;

R 3 is selected from the group consisting of NRC(O)R 6 , C(O)OR 6 , and (CH 2 ) n C 5-10 heterocycle, said heterocycle, optionally substituted with 1 to 3 groups of R a ;

R 5 is (CH 2 ) n C 6-10 aryl, (CH 2 ) n C 5-10 heterocycle, (CH 2 ) n C 3-10 cycloalkyl, said cycloalkyl, heterocycle, and aryl optionally substituted with 1 to 3 groups of R a ;

R 6 is selected from the groups consisting of H, C 1-6 alkyl, OR, (CH 2 ) n C 3-10 cycloalkyl, —NH(CH 2 ) n OR, (CH 2 ) n C 6-10 aryl, —N(R) 2 , (CH 2 ) n C 6-10 heterocyle, said alkyl, cycloalkyl, heterocycle, and aryl optionally substituted with 1 to 3 groups of R a ;

R a is selected from the group consisting of:

(1) halogen,

(2) hydroxyl,

(3) C 1-6 alkyl, which is unsubstituted or substituted with 1 to 3 groups of R b ,

(4) —O—C 1-6 alkyl, which is unsubstituted or substituted with 1 to 3 groups of R b ,

(5) (CH 2 ) n C 6-10 aryl, which is unsubstituted or substituted with 1 to 3 groups of R b ,

(6) —O—(CH 2 ) n C 5-10 heterocycle, which is unsubstituted or substituted with 1 to 3 groups of R b ,

(7) —(CH 2 ) n C 5-10 heterocycle, which is unsubstituted or substituted with 1 to 3 groups of R b ,

(8) —O—(CH 2 ) n C 6-10 aryl, which is unsubstituted or substituted with 1 to 3 groups of R b

(9) —(CH 2 ) n C 6-10 aryl, which is unsubstituted or substituted with 1 to 3 groups of Rb

(10) —O—(CH 2 ) n C 3-10 cycloalkyl, which is unsubstituted or substituted with 1 to 3 groups of R b ,

(11) —(CH 2 ) n C 3-10 cycloalkyl, which is unsubstituted or substituted with 1 to 3 groups of R b ,

(12) —NH—C 1-6 alkyl, or —N(C 1-6 alkyl)(C 1-6 alkyl), which is unsubstituted or substituted with 1 to 3 groups of R b ,

(13) —O—(CH 2 ) n SO 2 C 6-10 aryl, which is unsubstituted or substituted with 1 to 3 groups of R b

(14) —(CH 2 ) n CO 2 R,

(15) —CN,

(16) —NO 2 ;

(17) —O) 0-1 C 1-5 haloalkyl;

(18) C 2-6 alkynylC 5-10 heterocycle, which is unsubstituted or substituted with 1 to 3 groups of R b ;

(19) C 2-6 alkenyl;

(20) C(O)R,

(21) NH(CH 2 ) n OR, —NH(CH 2 ) n C 6-10 aryl, —NH(CH 2 ) n C 3-10 cycloalkyl, —NH(CH 2 ) n C 1-6 alkyl, —NRR, —NHC(O)C 1-6 alkyl, —N(C 1-6 alkyl)(CH 2 ) n C 6-10 aryl, or —NHSO 2 C 1-6 alkyl, said alkyl, cycloalkyl and aryl optionally substituted with 1 to 3 groups of R b

R b is selected from the group consisting of:

(1) halogen,

(2) hydroxyl,

(3) C 1-6 alkyl,

(4) —O—C 1-6 alkyl,

(5) (CH 2 )nC 6-10 aryl,

(6) (CH 2 ) n C 5-10 heterocycle,

(7) C 1-5 haloalkyl; and

n represents 0-4;

or a pharmaceutically acceptable salt thereof.

2. The compound according to claim 1 wherein R 3 is (CH 2 ) n C 5-10 heterocycle, said heterocycle optionally substituted with 1 to 3 groups of Ra.

3. The compound according to claim 2 wherein R 3 is selected from the group consisting of pyrimidinyl, pyrimidinon-yl, pyridyl, pyridinon-yl, benzimidazoly, thiazolyl, oxazolyl, thiadiazolyl, imidazolyl, benzoxazolyl, naphthyridinyl, quinolinyl, isoquinolinyl, pyrazolopyridinyl, imidazopyridinyl, and imidazopyrimidinyl, said groups optionally substituted with 1 to 3 groups of R a .

4. The compound according to claim 1 wherein R 3 is selected from the group consisting of NRC(O)R 6 , and C(O)OR 6 .

5. The compound according to claim 1 wherein at least one of X 1 , X 2 and X 3 is nitrogen.

6. The compound according to claim 5 wherein two of X 1 , X 2 and X 3 is nitrogen and the other is CH.

7. The compound according to claim 1 wherein R 5 is selected from the group consisting of triazolyl, imidazolyl, pyrazolyl, pyradazinyl, pyrimidinyl, pyrazinyl, triazinyl, pyridyl, and piperazinyl, said groups optionally substituted with 1 to 3 groups of R a .

8. The compound according to claim 7 wherein R 5 is triazoly, pyridyl, pyrazolyl, or pyridazinyl, said group optionally substituted with 1 to 3 groups of R a .

9. The compound according to claim 1 of formula I represented by structural formula II:

or a pharmaceutically acceptable salt thereof, wherein R 2 , and R a are as originally described, and R 1 is selected from the groups consisting of H, O—C 1-6 alkyl, C 1-6 alkyl, (CH 2 ) n C 3-10 cycloalkyl, (CH 2 ) n C 6-10 aryl, and (CH 2 ) n C 5-10 heterocycle, said alkyl, heterocycle, and aryl optionally substituted with 1 to 3 groups of R b .

10. The compound according to claim 9 wherein R 2 is CN, CF 3 , CF 2 , C 1-6 alkyl, O—C 1-6 alkyl, C 3-10 cycloalkyl, or (CH 2 ) n C 5-10 heterocyle, R 1 is (CH 2 ) n C 6-10 aryl, (CH 2 ) n C 5-10 heterocyle, or C 1-6 alkyl, said alkyl, cycloalkyl heterocycle, and aryl optionally substituted with 1 to 3 groups of R b .

11. The compound according to claim 1 of formula I represented by structural formula III:

or a pharmaceutically acceptable salt thereof, wherein R 2 , and R a are as originally described, B is pyridyl, and R 1 is selected from the groups consisting of H, O—C 1-6 alkyl, C 1-6 alkyl, (CH 2 ) n C 3-10 cycloalkyl, (CH 2 ) n C 6-10 aryl, (CH 2 ) n C 5-10 heterocycle, said alkyl, heterocycle, and aryl optionally substituted with 1 to 3 groups of R b .

12. The compound according to claim 11 wherein R 2 is CN, CF 3 , CF 2 , C 1-6 alkyl, O—C 1-6 alkyl, C 3-10 cycloalkyl, or (CH 2 ) n C 5-10 heterocyle, R 1 is (CH 2 ) n C 6-10 aryl, (CH 2 ) n C 5-10 heterocyle, or C 1-6 alkyl, said alkyl, cycloalkyl heterocycle, and aryl optionally substituted with 1 to 3 groups of R b .

13. A compound which is:

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(1H-pyrazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(2-methoxy-6-(4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(6-(4-methyl-1H-pyrazol-1-yl)-2-(trifluoromethyl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(2-cyclopropyl-6-(4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3,4-dimethyl-1H-pyrazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(3,4,5-trimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(3-(trifluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(6-(3-methoxy-1H-pyrazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3-cyclopropyl-1H-pyrazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3-isopropyl-1H-pyrazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(4-ethyl-1H-pyrazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(4-(trifluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)-1H-pyrazole-4-carbonitrile,

2-(1-(6-(4-methoxy-1H-pyrazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

(1-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)-1H-pyrazol-4-yl)methanol,

1-(1-{2-methoxy-6-3-(1-methyl-1H-benzimidazol-2-yl)azetidin-1-yl]pyrimidin-4-yl}-1H-pyrazol-4-yl)ethanol,

1-methyl-2-(1-(2-methyl-6-(5-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(6-(3,5-diethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-(methylthio)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

methyl 4-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidine-2-carboxylate,

2-(4-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-2-yl)acetonitrile,

ethyl 2-(4-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-2-yl)acetate,

1-methyl-2-(1-(2-methyl-6-(5-methyl-1H-1,2,3-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(4-methyl-2H-1,2,3-triazol-2-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(4-methyl-1H-1,2,3-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(6-(4-methyl-1H-1,2,3-triazol-1-yl)-2-(trifluoromethyl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(6-(4-methyl-2H-1,2,3-triazol-2-yl)-2-(trifluoromethyl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(2-cyclopropyl-6-(4-methyl-1H-1,2,3-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(2-cyclopropyl-6-(4-methyl-2H-1,2,3-triazol-2-yl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-{1-[2-methoxy-6-(4-methyl-2H-1,2,3-triazol-2-yl)pyrimidin-4-yl]azetidin-3-yl}-1-methyl-1H-benzimidazole,

2-(1-(6-(5-ethyl-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(5-cyclopropyl-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(3-methyl-5-(tetrahydro-2H-pyran-4-yl)-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(3-methyl-5-propyl-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(6-(5-isopropyl-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

(S)-1-(3-methyl-1-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)-1H-1,2,4-triazol-5-yl)propan-2-ol,

(R)-1-(3-methyl-1-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)-1H-1,2,4-triazol-5-yl)propan-2-ol,

2-(1-(6-(5-(2-methoxyethyl)-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

methyl 3-(3-methyl-1-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)-1H-1,2,4-triazol-5-yl)propanoate,

ethyl 2-(3-methyl-1-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)-1H-1,2,4-triazol-5-yl)acetate,

2-(1-(6-(5-cyclohexyl-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(3-methyl-5-(phenoxymethyl)-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-4-(3-methyl-1-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)-1H-1,2,4-triazol-5-yl)pyrrolidin-2-one,

1-((3-methyl-1-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)-1H-1,2,4-triazol-5-yl)methyl)pyrrolidin-2-one,

1-methyl-2-(1-(2-methyl-6-(3-methyl-5-phenyl-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(6-(5-(2-chlorophenyl)-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(5-(2-fluorophenyl)-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(3-methyl-5-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(3-methyl-5-(5-methylpyrazin-2-yl)-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

4-(3-methyl-1-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)-1H-1,2,4-triazol-5-yl)benzonitrile,

1-methyl-2-(1-(2-methyl-6-(3-methyl-5-(6-methylpyridin-3-yl)-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(6-(5-(2,6-difluorophenyl)-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(5-(2,5-difluorobenzyl)-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(5-(4-fluorobenzyl)-3-methyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-{6-[5-(methoxymethyl)-3-methyl-1H-1,2,4-triazol-1-yl]-2-methylpyrimidin-4-yl}azetidin-3-yl)-1-methyl-1H-benzimidazole,

2-{1-[6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-(trifluoromethyl)pyrimidin-4-yl]azetidin-3-yl}-1-methyl-1H-benzimidazole,

2-{1-[2-cyclopropyl-6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl]azetidin-3-yl}-1-methyl-1H-benzimidazole,

2-{1-[6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methoxypyrimidin-4-yl]azetidin-3-yl}-1-methyl-1H-benzimidazole,

2-(1-(6-(5-cyclopropyl-3-methyl-1H-1,2,4-triazol-1-yl)-2-methoxypyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(5-ethyl-3-methyl-1H-1,2,4-triazol-1-yl)-2-methoxypyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(2-cyclopropyl-6-(5-(methoxymethyl)-3-methyl-1H-1,2,4-triazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(5-(methoxymethyl)-3-methyl-1H-1,2,4-triazol-1-yl)-2-(trifluoromethyl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(5-ethyl-3-methyl-1H-1,2,4-triazol-1-yl)-2-(trifluoromethyl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(5-cyclopropyl-3-methyl-1H-1,2,4-triazol-1-yl)-2-(trifluoromethyl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(6-(3-methyl-5-(tetrahydro-2H-pyran-4-yl)-1H-1,2,4-triazol-1-yl)-2-(trifluoromethyl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-{1-[6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-isopropoxypyimidin-4-yl]azetidin-3-yl}-1-methyl-1H-benzimidazole,

5-(((4-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-2-yl)oxy)methyl)isoxazole,

2-(((4-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-2-yl)oxy)methyl)thiazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-(1-methyl-1H-pyrazol-5-yl)methoxy)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

3-(((4-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-2-yl)oxy)methyl)isoxazole,

5-(((4-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-2-yl)oxy)methyl)-3-methyl-1,2,4-oxadiazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-(1H-pyrazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-(2-methyl-1H-imidazol-1-yl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-{1-[6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-(pyrrolidin-1-yl)pyrimidin-4-yl]azetidin-3-yl}-1-methyl-1H-benzimidazole,

4-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-6-[3-(1-methyl-1H-benzimidazol-2-yl)azetidin-1-yl]pyrimidine-2-carbonitrile,

1-Methyl-2-(1-(2-methyl-6-(2-methylpyridin-3-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(pyridin-3-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(6-(2-methoxypyridin-3-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

N-(3-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)pyridin-2-yl)acetamide,

2-(1-(6-(2-methoxy-6-methylpyridin-3-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(2-fluoro-6-methylpyridin-3-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(pyridin-4-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(6-(trifluoromethyl)pyridin-2-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-phenylpyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(6-(2-methoxyphenyl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(2-fluorophenyl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(2-(difluoromethoxy)phenyl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)phenol,

2-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)benzoic acid,

1-methyl-2-(1-(2-methyl-6-(5-methylpyridin-2-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(pyridin-2-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(2-methoxy-6-(5-methylpyridin-2-yl)pyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-methyl-2-(1-(6-(5-methylpyridin-2-yl)-2-(trifluoromethyl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

1-methyl-2-(1-(2-methyl-6-(6-methylpyridin-2-yl)pyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(6-(5-chloropyridin-2-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3-methoxypyridin-2-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-1H-benzo[d]imidazole,

1-(2-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)pyridin-4-yl)ethanone,

1-(6-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)pyridin-3-yl)ethanone,

6-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)nicotinonitrile,

2-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)oxazole,

2-(2-methyl-6-(3-(1-methyl-1H-benzo[d]imidazol-2-yl)azetidin-1-yl)pyrimidin-4-yl)thiazole,

1-methyl-2-{1-[2-methyl-6-(pyridazin-3-yl)pyrimidin-4-yl]azetidin-3-yl}-1H-benzimidazole,

2-(1-(6-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-7-fluoro-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-6-fluoro-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-7-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-6-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-7-(trifluoromethyl)-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-6-(trifluoromethyl)-1H-benzo[d]imidazole,

2-(1-(6-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-ethyl-1H-benzo[d]imidazole,

2-(2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazol-1-yl)acetonitrile,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-(2-fluoroethyl)-1H-benzo[d]imidazole,

2-(2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazol-1-yl)ethanol,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-propyl-1H-benzo[d]imidazole,

3-(2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazol-1-yl)propanenitrile,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-(2-ethoxyethyl)-1H-benzo[d]imidazole,

4-(2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1H-benzo[d]imidazol-1-yl)butanenitrile,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-4-fluoro-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-7-fluoro-1-methyl-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1,4-dimethyl-1H-benzo[d]imidazole,

2-(1-(6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2-methylpyrimidin-4-yl)azetidin-3-yl)-1-methyl-4-(trifluoromethyl)-1H-benzo[d]imidazole,

4-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)-2-methyl-6-[3-(5-methylpyridin-2-yl)azetidin-1-yl]pyrimidine,

or a pharmaceutically acceptable salt thereof.

14. A pharmaceutical composition which comprises a pharmaceutically acceptable carrier and a compound of claim 1 or a pharmaceutically acceptable salt thereof.

Assignments (3)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL NO. 13/349,041 PREVIOUSLY RECORDED AT REEL: 034127 FRAME: 0820. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 3, 2014
From: BESHORE, DOUGLAS C.; COX, CHRISTOPHER D.; KIM, JUNE J.; STEEN, JUSTIN T.; REGER, THOMAS; MCVEAN, CAROL A.; KUDUK, SCOTT D.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 034741/0736 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2014
From: BESHORE, DOUGLAS C.; COX, CHRISTOPHER D.; KIM, JUNE J.; STEEN, JUSTIN T.; REGER, THOMAS; MCVEAN, CAROL A.; KUDUK, SCOTT D.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 034127/0820 →